Captor Therapeutics S.A. (CTX) — Net Asset Momentum
Captor Therapeutics S.A. (CTX) recorded a net asset momentum of -6.9% as of December 2024, with net assets of zł64.47 Million PLN. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Captor Therapeutics S.A. to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Captor Therapeutics S.A. Net Asset Momentum (2017–2024)
This chart tracks Captor Therapeutics S.A.'s year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -6.9%, with net assets of zł64.47 Million PLN as of December 2024. Read CTX current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Captor Therapeutics S.A. (2017–2024)
The table below shows the complete annual net asset history for Captor Therapeutics S.A. from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see CTX company net worth.
| Year | Net Assets (PLN) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | zł64.47 Million | zł87.50 Million | zł23.02 Million | ▼ -6.9% |
| 2023 | zł69.22 Million | zł97.29 Million | zł28.07 Million | ▼ -28.1% |
| 2022 | zł96.32 Million | zł113.00 Million | zł16.68 Million | ▼ -22.4% |
| 2021 | zł124.20 Million | zł143.54 Million | zł19.34 Million | ▲ +12470.6% |
| 2020 | zł-1.00 Million | zł25.78 Million | zł26.78 Million | ▼ -123.5% |
| 2019 | zł4.28 Million | zł25.30 Million | zł21.02 Million | ▲ +24.7% |
| 2018 | zł3.43 Million | zł18.06 Million | zł14.63 Million | ▲ +2282.6% |
| 2017 | zł144.00K | zł5.12 Million | zł4.98 Million | — |